| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	
																	Bentrio™ formulation well tolerated in vitro on human nasal epithelium Up to 99% reduction of SARS-CoV-2 viral titer with...
																	Treatment of KRAS-driven colorectal cancer selected as first therapeutic indication for OligoPhore™ platform Company to laun...
																	
																	
																	Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T...
																	Auris Medical Holding Ltd (NASDAQ: EARS) shares are trading higher by 12.7% at $4.16 Thursday morning after the company announc...
																	
																	Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...